journal article·2015-10

miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy

Shiqian Gao, Huayu Tian, Ye Guo, Yuce Li, Zhaopei Guo, Xiaojuan Zhu, Xuesi Chen

Acta Biomaterialia· Volume 25
Publisher page

Abstract

MicroRNA-21 (miR-21) inhibition is a promising biological strategy for breast cancer therapy. However its application is limited by the lack of efficient miRNA inhibitor delivery systems. As a cationic polymer transfection material for nucleic acids, the poly (l-lysine)-modified polyethylenimine (PEI-PLL) copolymer combines the high transfection efficiency of polyethylenimine (PEI) and the good biodegradability of polyllysine (PLL). In this work, PEI-PLL was successfully synthesized and confirmed to transfect plasmid and oligonucleotide more effectively than PEI in MCF-7 cells (human breast cancer cells). In this regard, two kinds of miR-21 inhibitors, miR-21 sponge plasmid DNA (Sponge) and anti-miR-21 oligonucleotide (AMO), were transported into MCF-7 cells by PEI-PLL respectively. The miR-21 expression and the cellular physiology were determined post transfection. Compared with the negative control, PEI-PLL/Sponge or PEI-PLL/AMO groups exhibited lower miR-21 expression and cell viability. The anti-tumor mechanism of PEI-PLL/miR-21 inhibitors was further studied by cell cycle and western blot analyses. The results indicated that the miR-21 inhibition could induce the cell cycle arrest in G1 phase, upregulate the expression of Programmed Cell Death Protein 4 (PDCD4) and thus active the caspase-3 apoptosis pathway. Interestingly, the PEI-PLL/Sponge and PEI-PLL/AMO also sensitized the MCF-7 cells to anti-tumor drugs, doxorubicin (DOX) and cisplatin (CDDP). These results demonstrated that PEI-PLL/Sponge and PEI-PLL/AMO complexes would be two novel and promising gene delivery systems for breast cancer gene therapy based on miR-21 inhibition. Statement of significance This work was a combination of the high transfection efficiency of polyethylenimine (PEI), the good biodegradability of polyllysine (PLL) and the breast cancer-killing effect of miR-21 inhibitors. The poly (l-lysine)-modified polyethylenimine (PEI-PLL) copolymer was employed as the vector of miR-21 sponge plasmid DNA (Sponge) or anti-miR-21 oligonucleotide (AMO). PEI-PLL showed more transfection efficiency and lower cytotoxicity in human breast cancer cells than PEI. Moreover, the breast cancer cells exhibited significantly lower miR-21 expression and cell viability post transfection with sponge or AMO. Interestingly, the PEI-PLL/miR-21 inhibitor complexes also sensitized the cancer cells to anti-cancer chemotherapy drugs, doxorubicin (DOX) and cisplatin (CDDP). This synergistic effect provides a good application prospect of co-delivery miR-21 inhibitors and chemical drugs in breast cancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · MicroRNA in disease regulation · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (32)

Show source-provided references
1. Breast cancer statistics, 201310.3322/caac.21203 ↗
2. Systematic screen of chemotherapeutics in Drosophila stem cell tumors10.1073/pnas.1401160111 ↗
3. Stimulus-responsive polyplexes with drug and gene co-delivery
4. MicroRNAs: genomics, biogenesis, mechanism, and function10.1016/S0092-8674(04)00045-5 ↗
5. Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition10.1016/j.actbio.2014.04.026 ↗
6. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth10.1186/bcr2803 ↗
7. MiR-21-mediated tumor growth10.1038/sj.onc.1210083 ↗
8. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis10.1038/cr.2008.24 ↗
9. MiR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression10.1093/carcin/bgs198 ↗
10. Progress in microRNA delivery10.1016/j.jconrel.2013.09.015 ↗
11. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells10.1038/nmeth1079 ↗
12. MicroRNA sponges: progress and possibilities10.1261/rna.2414110 ↗
13. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 810.1073/pnas.0706059104 ↗
14. MicroRNAs and other non-coding RNAs as targets for anticancer drug development10.1038/nrd4140 ↗
15. Cationic lipids and polymers mediated vectors for delivery of siRNA10.1016/j.jconrel.2007.07.016 ↗
16. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo – polyethylenimine10.1073/pnas.92.16.7297 ↗
17. Hydrophobic poly (amino acid) modified PEI mediated delivery of rev-casp-3 for cancer therapy10.1016/j.biomaterials.2012.02.057 ↗
18. Nanoparticles for gene delivery10.1002/smll.201202485 ↗
19. Contribution of cholesterol moieties attached on MPEG-b-PCL-b-PLL to the cell uptake, endosomal escape and gene knockdown of the micelleplexes of siRNA10.1007/s10118-013-1288-6 ↗
20. Polylysine-modified polyethylenimine inducing tumor apoptosis as an efficient gene carrier10.1016/j.jconrel.2013.06.026 ↗
21. An unconventional method for purifying the N-carboxyanhydride derivatives of γ-alkyl-L-glutamates10.1080/00397919908086042 ↗
22. The preparation of N-carboxyanhydrides of α-amino acids using bis(trichloromethyl)carbonate10.1016/S0040-4039(00)82209-1 ↗
23. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells10.1158/0008-5472.CAN-08-1305 ↗
24. Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery10.1021/ja0436446 ↗
25. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma10.1093/hmg/dds496 ↗
26. Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/Caspase-3 axis10.1161/HYPERTENSIONAHA.113.03037 ↗
27. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-2110.1016/j.ccr.2010.08.013 ↗
28. Multi-armed poly(aspartate-g-OEI) copolymers as versatile carriers of pDNA/siRNA10.1016/j.actbio.2013.02.007 ↗
29. Folic acid conjugated amino acid-based star polymers for active targeting of cancer cells10.1021/bm200604h ↗
30. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)10.1074/jbc.M611393200 ↗
31. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma10.1016/j.biomaterials.2013.11.039 ↗
32. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN10.1371/journal.pone.0039520 ↗